SCHEMBL10366186

SCHEMBL10366186

CC(c1ccc2c(c1)CCC(Cc1ccccc1)O2)C1SC(=O)NC1=O

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.36
▸ SIGMAR1 Q99720 2/20 0.36
▸ DDB1 Q16531 1/20 0.35
▸ CRBN Q96SW2 1/20 0.35
▸ DRD2 P14416 9/20 0.34
▸ DRD4 P21917 9/20 0.34
▸ DRD3 P35462 9/20 0.34
▸ DRD1 P21728 2/20 0.33
▸ DRD5 P21918 2/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10685328 0.82 CYP26A1 (0.50) HTR1ASIGMAR1DDB1CRBN
SCHEMBL10685155 0.80 S1PR1 (0.40) HTR1ASIGMAR1DDB1CRBNFFAR1
Englitazone SCHEMBL4727851 0.79 PPARG (0.50) FFAR1
Englitazone SCHEMBL29377687 0.79 PPARG (0.50) FFAR1
Englitazone SCHEMBL20125579 0.79 PPARG (0.50) FFAR1
Englitazone SCHEMBL37697 0.79 PPARG (0.50) FFAR1
Englitazone SCHEMBL20125577 0.79 PPARG (0.50) FFAR1
SCHEMBL10685552 0.78 TSHR (0.34) DDB1CRBNFFAR1TSHR
Englitazone SCHEMBL22607925 0.78 PPARG (0.49) FFAR1
Englitazone SCHEMBL8522765 0.78 PPARG (0.49) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0207605-B1 HYPOGLYCEMIC THIAZOLIDINEDIONES PFIZER INC. (US) 1990-02-07 — — EP disclosed
US-4703052-A Hypoglycemic thiazolidinediones PFIZER INC. (US) 1987-10-27 — — US disclosed
WO-1986007056-A1 HYPOGLYCEMIC THIAZOLIDINEDIONES PFIZER INC. (US) 1986-12-04 — — WO disclosed
Send feedback